Resources

Past Presentation

Public Health and Scientific Challenges | IHS Epidemiology Update | Monoclonal Antibodies | January 7, 2021

Date of Presentation: January 7, 2021

Type: Past Presentation  

Audience: Clinical  

Program: Virology  

Keywords: #fauci  #monoclonal antibodies  #national update  

In this series of presentations, Dr. Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, discusses COVID-19 public health and scientific challenges. Then Dr. Michael Toedt, Medical Director for the Indian Health Service, gives a national update on COVID-19 epidemiology. Finally, Dr. Jonathan Iralu, Chief Clinical Consultant for Infectious Diseases at IHS, gives a clinical update on monoclonal antibodies.

 

Recording:

Presented by:

Dr. Anthony Fauci, Dr. Jonathan Iralu, RADM Michael Toedt

Anthony S. Fauci, MD, MPH, is the Director for the National Institute of Allergy and Infectious Diseases at the National Institutes of Health

Jonathan Iralu, MD, FACP, is the Indian Health Service Chief Clinical Consultant for Infectious Diseases. He has a special interest in HIV, tuberculosis and sexually transmitted disease care in rural communities. His research has focused on undifferentiated febrile illness in the American Southwest and on rural HIV care delivery. Dr. Iralu has worked at the Gallup Indian Medical Center since 1994 and is an instructor at Harvard Medical School and Senior Physician at Brigham and Women’s Hospital Division of Global Health Equity in Boston, Massachusetts.

Michael Toedt, MD, FAAFP, is the Medical Director for the Indian Health Service

Resources Provided:

Date added: January 7, 2021